Design and synthesis of potent and selective inhibitors of integrin VLA-4

Bioorganic and Medicinal Chemistry Letters

Volumn 11, Issue 22, 2001, Pages 2955-2958

  Wattanasin, Sompong ^a   Weidmann, Beat ^a   Roche, Didier ^a   Myers, Stewart ^a   Xing, Amy ^a   Guo, Qin ^a   Sabio, Michael ^a   von Matt, Peter ^a   Hugo, Ronald ^a   Maida, Susan ^a   Lake, Philip ^a   Weetall, Marla ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD29 ANTIGEN INHIBITOR; IMMUNOLOGIC AGENT; INTEGRIN; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; DRUG DESIGN; DRUG IDENTIFICATION; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; REACTION ANALYSIS;

ANTI-ALLERGIC AGENTS; DRUG DESIGN; INTEGRIN ALPHA4BETA1; INTEGRINS; PEPTIDES; RECEPTORS, LYMPHOCYTE HOMING; RECEPTORS, VERY LATE ANTIGEN; STRUCTURE-ACTIVITY RELATIONSHIP; UREA;

EID: 0035914621     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(01)00586-8     Document Type: Article

References (26)